| | Fifteen-day Acupuncture Treatment Relieves Diabetic Peripheral NeuropathyReceived 21 February 2010; accepted 12 April 2010. Abstract Our study aimed to investigate the effects of acupuncture on diabetic peripheral neuropathy. We compared 42 cases treated with acupuncture with 21 cases exposed to sham acupuncture and observed the effects on nerve conduction velocity and a variety of subjective symptoms associated with diabetic peripheral neuropathy. Three of the six measures of motor nerves, and two measures of sensory function, demonstrated significant improvement (p < 0.05) over the 15-day treatment period in the acupuncture group, while no motor or sensory function significantly improved in the sham acupuncture group. There were also significant differences in vibration perception threshold between the groups (p < 0.05) and when compared to the baseline levels (p < 0.01) in the acupuncture group. Acupuncture was significantly more effective than sham for treatment of numbness of the lower extremities, spontaneous pain in the lower extremities, rigidity in the upper extremities and alterations in temperature perception in the lower extremities after therapy. Our pilot study has, therefore, provided evidence that acupuncture may be clinically useful for the radical treatment of diabetic peripheral neuropathy.
1. Introduction  Diabetic peripheral neuropathy (DPN) is the most common late complication of diabetes, often associated with considerable morbidity and mortality [1]. It is estimated that 12–50% of people with diabetes have some degree of DPN [2]. Approximately 15% of people with diabetes develop at least one foot ulcer during their lifetime [3, 4]. While vascular disease leading to ischemia is certainly a factor in the pathogenesis, 60–70% of diabetic foot ulcers are primarily neuropathic in origin [4]. DPN may be asymptomatic. When symptoms are present, they may be negative or positive. Negative symptoms include loss of sensation and strength, while positive symptoms include prickling or pain [5]. Affected nerve functions include reduced nerve conduction velocity, decreased temperature sensation, decreased tendon reflex response, and a decreased ability to detect vibration and touch. The pathophysiology of DPN remains unclear, although it is associated with increased age, duration of diabetes, lipotoxicity and glucotoxicity, genetic susceptibility, inflammation, and oxidative stress [6, 7]. The total annual cost of DPN and its complications in the United States was estimated to be more than four billion. Up to 27% of the direct medical cost of diabetes may be attributed to DPN [8]. Although several pivotal trials have shown that strict glycemic control reduces the occurrence and progression of diabetes-related complications [9, 10], this approach alone does not completely eliminate complications. Thus the development of new therapy to manage diabetes complications remains a high priority. Acupuncture, one of the oldest and most commonly used forms of alternative medicine, has existed for more than 2500 years. Acupuncture is a meridian-based therapy. In traditional acupuncture, needles are inserted into precisely defined, specific points on the body, each of which has distinct therapeutic actions [11]. According to traditional Chinese medicine (TCM), when an acupoint is stimulated, treatment effects tend to occur on the specific parts of the body along a particular meridian that contains this specific acupoint. In vestigators have demonstrated that the nervous system and neurotransmitters respond to needling stimulation and electroacupuncture [12, 13, 14]. As a safe form of treatment [15, 16], acupuncture offers clear clinical advantages in the reduction of symptoms related to nervous disorders. Paul et al [17] reported that two of the total three patients showed increased benefit when a series of six acupuncture sessions was added to the ongoing nefazodone therapy for the treatment of DPN. Unfortunately, to date, only a few trials on acupuncture have specifically targeted DPN. In a randomized controlled trial in China, Chen et al [18] concluded that the point through point method of acupuncture was superior to mecobalamin for the improvement of motor nerve conduction velocity (MNCV) of the common peroneal nerve. The results of another randomized trial showed that acupuncture lowered the pain caused by painful DPN [19]. Given these findings, we also performed a prospective randomized controlled trial to investigate whether acupuncture is useful for DPN.
2. Materials and Methods  2.1. Study site and participants The study was conducted at the Jilin Chinese Medical Hospital between June 2005 and December 2005. DPN patients aged 35–52 years were invited to participate. 2.2. Study protocol The study protocol was approved by the Jilin Chinese Medical Hospital. Protocol summaries were reviewed by the participants, and written, informed consent was obtained on the day of the study after a detailed explanation of the study purpose and methods. These participants were diagnosed with mild DPN based on subjective symptoms, no foot ulceration, and neurological dysfunctions (at least two parameters: MNCV [indispensable] and vibration perception threshold [VPT] or Achilles tendon reflex). MNCV in the tibial nerve of patients ranged between 30 m/s and 45 m/s. Participants' sensory nerve conduction velocity (SNCV) in the median nerve (the distal area) ranged between 35 m/s and 55 m/s with stable glycemic control (HbA1C ≤ 9%, with ±0.5% variation in the previous 3 months). Subjects were excluded if their primary cause of neurologic disorder was not diabetes (e.g., alcoholic neuropathy, carpal tunnel syndrome, sequelae of cerebrovascular disease,), if their F-wave response had disappeared, if they had arteriosclerosis obliterans (ankle brachial pressure index of ≤ 0.8) or severe hepatic or renal disorder, if they were participating in other interventional studies, or if they were receiving other experimental medications for DPN, prostaglandin E1 preparations, or any other medication that affects symptoms of DPN. After the baseline period, 63 participants meeting the inclusion criteria were randomized (by random number table) into one of the two groups in a 2:1 ratio (acupuncture group and sham acupuncture group) which differed only in the type of needle manipulation used. This randomization meant 42 cases were allocated to the acupuncture group and 21 cases to the sham acupuncture group. There were no statistically significant differences (p > 0.05) between the two groups in any of the baseline characteristics. Table 1 shows the baseline characteristics for all 63 patients. |
*
Values expressed as mean (SD) unless otherwise indicated. BMI = body mass index; DPN = diabetic peripheral neuropathy; MNCV = motor nerve conduction velocity; SNCV = sensory nerve conduction velocity; VPT = vibration perception threshold.
|
Both groups continued conventional therapy (diet treatment, hypoglycemic agents, insulin and hypotensive agents) with medication to aid neuropathy control prohibited. No major changes in diabetic management had taken place during the 3 months before the study, and no therapeutic alteration was made throughout the study. All patients participated in one session per day lasting 30 minutes for 15 days, during which a total of five acupuncture point locations on the body received acupuncture needling. Sterile disposable one-time-use needles were used. For each location, a pair of corresponding acupoints on the right and left sides of the body were identified and marked with a skin marker (10 acupoints total). These acupoints were Hegu (LI4), Fenglong (ST40), Quchi (LI11), Zusanli (ST36), and San Yin Jiao (SP6) identified by an experienced acupuncturist (Jianmin Lang) according to traditional methods. Approximate position was determined in relation to anatomic landmarks (e.g., bones, tendons) and proportional measurements (e.g., fraction of the distance between wrist and elbow creases) [20]. Within this delineated area, the precise position of each acupoint was determined by palpation, feeling for a slight depression or yielding of tissues. For each acupoint, a needle 0.3 mm in diameter and 50 mm in length was used with 1.2–2.3 cm penetration, in a direction perpendicular to the surface of skin. The depth of insertion was between 1.20–1.53 cm for LI4, 1.82–2.25 cm for ST40, 1.38–1.50 cm for LI11, 2.11–2.30 cm for ST36 and 1.73–2.00 cm for SP6 with achievement of “De qi” (a sensory component perceived by the patient as an ache or heaviness in the area surrounding the needle and another simultaneous component, needle grasp, perceived by the acupuncturist [20]). The needle was then rotated alternately either clockwise or counterclockwise every 5 minutes. For sham acupuncture treatment, the same acupoints were punctured with the same acupuncture needles; however, the needle was inserted to a depth of only 0.3 cm, and no manipulation of the needle was performed, to avoid De qi [21]. Number, duration and frequency of the sessions in the sham acupuncture group were the same as for the acupuncture group. At the end of treatment, the success of blinding was tested by asking all patients the following question: “When you volunteered for the trial, you were informed that you had an equal chance of receiving acupuncture or sham (pretend) acupuncture. Which acupuncture do you think you received?” The primary end points for clinical efficacy were the differences between baseline and post-treatment electrophysiological measurements of the median motor nerve (F-wave minimum latency, MNCV, and F-wave conduction velocity [FCV]), the tibial motor nerve (F-wave minimum latency, MNCV, and FCV), and the median sensory nerve (forearm SNCV and distal SNCV). The method to measure nerve function was that according to Kohara et al [22] using electromyography (DISA1500; DISA, Herlev, Denmark). F-wave was measured 16 times, and the minimum was adopted. VPT was measured on the medial malleolus in the lower extremities using a hand-held biothesiometer (Biomedical Instruments, Newbury, OH, USA) [23, 24]. The voltage of vibration was increased until the patient could perceive a vibration. This was conducted three times. The mean of these three trials was used to determine the VPT. Symptoms were assessed using a standardized and comprehensive questionnaire at baseline and following 15 days of treatment. The symptoms assessed included measures of numbness, pain, rigidity (rigidity is a state of continuous, firm and tense muscles with marked resistance to passive movement), alterations in temperature perception, paresthesia, hypesthesia and weakness. For these sym ptoms, both the severity and extent were scored on an ascending 0–4 scale. For each symptom category, data were analyzed for all subjects in the efficacy pool who reported the symptom during the course of the study. Because not all symptoms were present in each subject, different subsets of subjects were included for each symptom. The specific scoring for severity of symptoms was as follows: 0=none (disappeared); 1=very slight (sometimes, but causes no problem at all in daily life); 2=slight (always, but causes no problem in daily life); 3=moderate (always, sometimes makes daily activity troublesome); and 4=severe (it makes daily activity troublesome). For the extent of symptoms, the scoring was as follows: 0=none; 1=only fingertips or ends of toes; 2=from wrist to fingertip or from ankle to toe; 3=from elbow to fingertip or from knee to toe; and 4=from above the elbow or above the knee. 2.3. Statistical analysis Statistical methods used included two-sample t tests for comparison of mean values between groups, paired t tests for comparison of mean values within groups, and two-way repeated analysis of variance for changes in glycemic control. All analyses were carried out using SAS version 8.02 (SAS Institute, Cary, NC, USA). A p value < 0.05 was considered statistically significant.
3. Results  3.1. Blinding data At the end of treatment, all patients were asked the following question: “When you volunteered for the trial, you were informed that you had an equal chance of receiving acupuncture or sham acupuncture. Which acupuncture do you think you received?” Of the 63 patients who gave an answer, two (9.5%) in the sham group believed that they had received sham acupuncture, all in the real acupuncture group believed that they had received real acupuncture. The blinding index was 0.32 (95% confidence interval [CI], 0.27 to 0.37) in the acupuncture group and −0.65 (95% CI, −0.61 to −0.69) in the sham group. The two proportions of unblinding were not significantly different (p=0.25). 3.2. Changes in glycemic control In the acupuncture group (n=42), HbA1C (mean±SD) at baseline and day 15 was 6.8±1.3 and 6.7±1.2% respectively. Corresponding values in the sham acupuncture group were 6.6±1.2% and 6.7±1.3%, respectively. There were no significant differences between the two groups at any time point. 3.3. Change in nerve function Table 2 outlines each electrophysiological measure (mean±SD) at baseline and end-of-treatment time points. Six measures assessed function in motor nerves, including F-wave minimum latency, MNCV and FCV in the median and tibial nerves. In the acupuncture group, three of the six measures in motor nerves demonstrated significant improvement (p < 0.05) over the 15-day treatment period. As expected, no electrophysiological measures of motor or sensory function significantly improved in the sham acupuncture group. |
*
p < 0.05 when compared to baseline, and when compared to sham acupuncture (SA) group
†
p < 0.01 when compared to baseline and when compared to SA group
‡
p < 0.01 when compared to baseline, p < 0.05 when compared to SA group. CI = confidence interval; MNCV = motor nerve conduction velocity; FCN = F-wave conduction velocity; SNCV = sensory nerve conduction velocity; VPT = vibration perception threshold.
|
The two measures of sensory function, forearm and distal SNCV, also improved in the acupuncture group. The change of forearm SNCV from baseline was significant (p < 0.05). There were also significant differences in VPT between groups (p < 0.05) and when compared to the baseline levels (p < 0.01) in the acupuncture group. 3.4. Changes in subjective symptoms over time Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8 show some of the changes in the score for subjective symptoms, in which a significant difference between the two groups was observed. As shown in the figures, the difference between the two groups gradually increased with continuous treatment. Acupuncture was significantly better than sham acupuncture for the treatment effects on numbness of lower extremities (severity p < 0.05, extent p < 0.05; Figure 1, Figure 2, respectively), spontaneous pain in lower extremities (severity p < 0.05, extent p < 0.01; Figure 3, Figure 4), rigidity in upper extremities (severity p < 0.05, extent p < 0.05; Figure 5, Figure 6), and alterations in temperature perception in lower extremities (severity p < 0.01, extent p < 0.05; Figure 7, Figure 8, respectively). Although the data are not shown in the figures, numbness in the upper extremities (severity), and sensation of rigidity (extent) were significantly improved in the acupuncture group compared with the sham acupuncture group (p < 0.05, and 0.01, respectively) after 15 days treatment. There was no significant difference between the two groups in the sensation of paresthesia, hypesthesia, and weakness of extremities.
4. Discussion  The peripheral nervous system is commonly affected in diabetic patients and the sequelae of nerve dysfunction often influence the final outcome of the disease. The pathophysiology of DPN remains controversial. Little is known about the etiology of loss of peripheral sensory neurons that accompanies DPN. Programmed cell death, or apoptosis, has been implicated in diabetic retinopathy and neuropathy [25], with impaired mitochondrial function being implicated in the promotion of apoptosis [26]. Increased polyol pathway activity has also been implicated in the pathogenesis of DPN [27]. Acupuncture is a safe form of treatment [15, 16, 28] and offers clear clinical advantages in the reduction of DPN related symptoms. This technique from Chinese medicine dates back at least 2500 years. According to the theory of Chinese medicine, health is a state of balance between yang and yin, between Qi and Xue, and between the five elements of wood, fire, earth, metal, and water [29]. Qi, or life energy, flows through the body in hypothesized channels called “meridians” and may be accessed at several hundred points. The traditional theory of acupuncture is based on the concept that an imbalance of yang and yin, through the meridians, can be corrected by manipulation of identifiable points close to the skin. The skilled acupuncturist is able to restore balance by using selected acupoints to adjust the energy flow. Each acupoint has distinct therapeutic actions. The stimulation of acupoints can be achieved by either a mechanical action of needling or electrical point stimulation [30]. Acupuncture was performed according to the rules of Chinese medicine, including diagnostic palpation to identify sensitive spots [20]. Acupoints refer to certain specifically located sites on the body, and according to TCM, these different specific points can be grouped into different categories in terms of their functional properties. Different groups of acupoints of the same type of functional property, which are located regularly on specific parts of the body, are the equivalent of 12 main meridians that respond to 12 major functions or “organs” of the body according to TCM. For DPN related symptoms, the most commonly used acupoints are Hegu (LI4), Fenglong (ST 40), Quchi (LI11), Zusanli (ST36) and San Yin Jiao (SP6). LI4, as Yuan-Source point, is of great significance in treating internal organ disease. LI4 strongly moves the Qi and blood in the body to remove stagnation, so indicated in every type of sensory or motor nerve disorders. The Yuan-source point from the affected meridian is often combined with the Luo-Connecting point of the internally-externally related meridians in use. ST40 is known as the Luo-Connecting point which can communicate with two meridians. ST40 is used to treat collateral disease and can be used to treat chronic diseases, especially chronic diseases of the Zang-Fu organs. It calms the Shen and clears phlegm from the heart by activating the meridian. So LI4 and ST40 are often used in combination for nervous disorders. LI11 and ST36 are the He-Sea points, where the Qi of the meridian collects and goes deep into the body. LI11 can clear heat, cool blood, resolve dampness, regulate Qi and blood, and activate the meridian. ST36 tonifies Qi and blood, harmonizes and strengthens the spleen and stomach, strengthens the body and Wei Qi, raises Yang, and calms the Shen. These two acupoints are also proven to be effective in nervous disorders. SP6 is one of the most commonly used points, and also one of the most versatile. Because SP6 crosses the spleen, kidney and liver meridians, it can treat many conditions associated with all three organs. This point nourishes blood and yin, cools and invigorates the blood, and calms the Shen. In this randomized trial, randomization was successfully concealed, achieving good credibility and blinding of participants receiving the nonpenetrating acupuncture intervention. The results show that acupuncture was more effective than sham acupuncture in improving nerve conduction velocity and a variety of subjective symptoms associated with DPN. F-wave measurements are particularly useful because they can detect abnormalities in any region of a peripheral nerve [31]. In the present study, differences in the reproducibility of F-wave minimum latency and FCV versus NCV measurements may account for the greater sensitivity of the former for detecting evidence of disease progression and acupuncture treatment effects. Also, acupuncture showed a significant improvement compared with sham acupuncture in F-wave minimum latency in tibial nerve measurements, FCV in measurements of the median motor nerve and MNCV in tibial nerve measurements. Improvement of nerve conduction function was considered to result in the effect of nerve degeneration, such as axonal atrophy in diabetic neuropathy [32]. These results suggest that acupuncture can delay the progressive deterioration of nerve function secondary to DPN. Although small and not present in every nerve, the observed significant changes in electrophysiological measures, combined with the improvement in symptoms, is especially encouraging in the diabetic population included in the present study. During the study, the difference in the subjective symptom scores between the acupuncture and sham acupuncture groups increased with time. Acupuncture treatment appeared to significantly improve subjective symptom scores, particular numbness, pain, rigidity and alterations in temperature perception. In DPN, although nerve fiber regeneration after nerve fiber loss is frequently observed in peripheral nerves, the process of regeneration appears to be delayed, and thus some regenerated nerve fibers remain immature. Abnormal excitement of these immature regenerated nerve fibers is thought to lead to numbness and spontaneous pain [33, 34]. Acupuncture treatment improved these symptoms, suggesting that it may accelerate the nerve regenerative process in DPN patients. Blinding indices, 0.32 (95% CI, 0.27 to 0.37) and −0.65 (95% CI, −0.61 to −0.69) in the acupuncture group and sham acupuncture group, respectively, imply that 32% of patients correctly guessed the treatment identity beyond chance, while 65% of patients in the sham acupuncture group incorrectly guessed that they had received acupuncture. Following the logic of Bang et al [35], these results indicate high “response bias”, which implies that a majority of study participants tend to believe that they were assigned a more effective intervention [36]. As mentioned above, acupuncture treatment not only improved nerve conduction velocity decreased by DPN, but also improved a variety of subjective symptoms associated with this progressive disabling disorder. Our pilot study has shown that the effects of acupuncture treatment on subjective symptoms as well as other measures of nerve function provide evidence that acupuncture, a form of alternative medicine, may be clinically useful for the radical treatment of DPN. Further studies with larger patient numbers are required to confirm our findings, to determine whether the effects are sustained, and to ascertain whether there are any effects on other sensory symptoms associated with DPN.
Acknowledgments  This research was funded by the Jilin Provincial Science and Technology Department. References  1.
1
Vinik AI
, Mehrabyan A
.
Diabetic neuropathies
.
Med Clin North Am
. 2004;88:947–999
.
Full Text |
Full-Text PDF (635 KB)
|
CrossRef
2.
2
Nicolucci A
, Carinci F
, Cavaliere D
, Scorpiglione N
, Belfiglio M
, Labbrozzi D
, et al.
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy
.
Diabet Med
. 1996;13:1017–1026
.
MEDLINE |
CrossRef
3.
3
Kantor J
, Margolis DJ
.
Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis
.
Dermatol Surg
. 2001;27:347–351
.
MEDLINE |
CrossRef
4.
4
Gonzalez ER
, Oley MA
.
The management of lower-extremity diabetic ulcers
.
Manag Care Interface
. 2000;13:80–87
.
MEDLINE 5.
5
Melton LJ
, Dyck PJ
.
Diabetic polyneuropathy
.
In:
Dyck PJ
, Thomas PK
editor.
Diabetic Neuropathy
. 2nd ed.. Philadelphia: WB Saunders; 1999;p. 49–50
.
6.
6
Schmader KE
.
Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy
.
Clin J Pain
. 2002;18:350–354
.
MEDLINE |
CrossRef
7.
7
Ziegler D
, Sohr CGH
, Nourooz-Zadeh J
.
Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy
.
Diabetes Care
. 2004;27:2178–2183
.
MEDLINE |
CrossRef
8.
8
Gordois A
, Scuffham P
, Shearer A
, Oglesby A
, Tobian JA
.
The health care costs of diabetic peripheral neuropathy in the US
.
Diabetes Care
. 2003;26:1790–1795
.
MEDLINE |
CrossRef
9.
9
Diabetes Control and Complications Trial Research Group
.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
.
N Engl J Med
. 1993;329:977–986
.
MEDLINE |
CrossRef
10.
10
UK Prospective Diabetes Study (UKPDS) Group
.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
.
Lancet
. 1998;352:837–853
.
Abstract | Full Text |
Full-Text PDF (708 KB)
|
CrossRef
11.
11
Hurtak JJ
.
An overview of acupuncture medicine
.
J Altern Complement Med
. 2002;8:535–538
.
MEDLINE 12.
12
Foster JMG
, Sweeney BP
.
The mechanisms of acupuncture analgesia
.
Br J Hosp Med
. 1987;38:308–312
.
MEDLINE 13.
13
Qian XZ
.
Progress in scientific research on acupuncture, moxibustion and acupuncture anesthesia by integrating traditional Chinese and Western medicine
.
In:
Zhang XT
editors.
Research on Acupuncture, Moxibustion, and Acupuncture Anesthesia
. Beijing: Science Press; 1986;
.
14.
14
Tang D
.
Advances of research on the mechanism of acupuncture and moxibustion
.
Acupunct Res
. 1987;4:278–284
.
15.
15
Lao L
.
Safety issues in acupuncture
.
J Altern Complement Med
. 1996;2:27–31
.
MEDLINE 16.
16
Huisheng Xie
, Ortiz-Umpierre Carolina
.
What acupuncture can and cannot treat
.
J Am Anim Hosp Assoc
. 2006;42:244–248
.
MEDLINE 17.
17
Paul JG
, Karen B
, Xue LW
, Adarsh K
.
Acupuncture and neuropathy
.
Am J Psychiatry
. 2000;157:1342–1343
.
CrossRef
18.
18
Chen YL
, Ma XM
, Hou WG
, Cen J
, Yu XM
, Zhang L
.
Effects of penetrating acupuncture on peripheral nerve conduction velocity in patients with diabetic peripheral neuropathy: a randomized controlled trial
.
Zhong Xi Yi Jie He Xue Bao
. 2009;7:273–275
.
CrossRef
19.
19
Ahn AC
, Bennani T
, Freeman R
, Hamdy O
, Kaptchuk TJ
.
Two styles of acupuncture for treating painful diabetic neuropathy-a pilot randomised control trial
.
Acupunct Med
. 2007;25:11–17
.
CrossRef
20.
20
Cheng X
.
Chinese Acupuncture and Moxibustion
. Beijing: Foreign Language Press; 1987;
.
21.
21
Vincent CA
.
A controlled trial of the treatment of migraine by acupuncture
.
Clin J Pain
. 1989;5:305–312
.
MEDLINE |
CrossRef
22.
22
Kohara N
, Kimura J
, Kaji R
, Goto Y
, Ishii J
, Takiguchi M
, et al.
F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy
.
Diabetologia
. 2000;43:915–921
.
CrossRef
23.
23
Armstrong DG
, Lavery LA
, Vela SA
, Quebedea TL
, Fleischli JG
.
Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration
.
Arch Intern Med
. 1998;158:289–292
.
MEDLINE |
CrossRef
24.
24
Young MJ
, Breddy L
, Veves A
, Boulton AJ
.
The prediction of diabetic neuropathic foot ulceration using vibratory perception thresholds
.
Diabetes Care
. 1994;17:557–560
.
MEDLINE 25.
25
Russell JW
, Sullivan KA
, Windebank AJ
, Herrmann DN
, Feldman EL
.
Neurons undergo apoptosis in animal and cell culture models of diabetes
.
Neurobiol Dis
. 1999;6:347–363
.
MEDLINE |
CrossRef
26.
26
Kroemer G
, Dallaporta B
, Resche-Rigon M
.
The mitochondrial death/life regulator in apoptosis and necrosis
.
Ann Rev Physiol
. 1998;60:619–642
.
27.
27
Soroku Y
, Shin-Ichiro Y
, Ryu-ichi W
, Masayuki B
, Thomas CH
, Chihiro YN
, et al.
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor
.
Brain
. 2001;124:2448–2458
.
MEDLINE |
CrossRef
28.
28
Ernst E
, White A
.
Life-threatening adverse reactions after acupuncture? A systematic review
.
Pain
. 1997;71:123–126
.
Full Text |
Full-Text PDF (48 KB)
|
CrossRef
29.
29
Connelly DM
.
Traditional Acupuncture: The Law of the Five Elements
. Columbia, MD: Traditional Acupuncture Institute; 1994;
.
30.
30
Hurtak JJ
.
An overview of acupuncture medicine
.
J Altern Complement Med
. 2002;8:535–538
.
MEDLINE 31.
31
Kimura J
.
Electrodiagnosis in Diseases of Nerve and Muscle: Principal and Practice
. Philadelphia: FA Davis; 1989;
.
32.
32
Arezzo JC
.
The use of electrophysiology for assessment of diabetic neuropathy
.
Neurosci Res Commun
. 1997;21:13–23
.
33.
33
Pfeifer MA
, Ross DR
, Schrage JP
, Gelber DA
, Schumer MP
, Crain GM
, et al.
A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy
.
Diabetes Care
. 1993;16:1103–1115
.
MEDLINE 34.
34
Portenoy RK
.
Painful polyneuropathy
.
Neurol Clin
. 1989;7:265–288
.
MEDLINE 35.
35
Bang H
, Ni L
, Davis CE
.
Assessment of blinding in clinical trials
.
Control Clin Trials
. 2004;25:143–156
.
Abstract | Full Text |
Full-Text PDF (184 KB)
|
CrossRef
36.
36
Hughes JR
, Krahn D
.
Blindness and the validity of the double-blind procedure
.
J Clin Psychopharmacol
. 1985;5:138–142
.
MEDLINE Department of Acupuncture, The First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China Corresponding author. The First Affiliated Hospital to Changchun University of Chinese Medicine, Department of Acupuncture, 1478 Gongnong Road, Changchun, Jilin 130021, China
PII: S2005-2901(10)60018-0 doi:10.1016/S2005-2901(10)60018-0 © 2010 Korean Pharmacopuncture Institute. Published by Elsevier Inc. All rights reserved. | |
|